Recently, Li et al. (2020) prepared a US therapeutic agent that encapsulates low boiling (bp = 29°C) perfluoropentane (PFP) into pH-sensitive cage protein ferritin (FRT) conjugated with the tumor-targeting molecule FA (FA-FRT-PFP) (Li et al., 2020). This evidence concerns the gene FLT1 and neoplasm.